Bemithyl treatment was carried out in 22 patients with neuromuscular diseases (progressive myodystrophy). The actoprotector bemithyl inhibited in these patients the processes of lipid peroxidation, activation of neoglucogenesis favours improvement of interorganic exchange of metabolites. Bemithyl is recommended in patients with progressive myodystrophy along with drugs normalizing the protein, energy and electrolyte metabolism.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients progressive
8
progressive myodystrophy
8
[the bemitil
4
patients
4
bemitil patients
4
progressive muscular
4
muscular dystrophies]
4
dystrophies] bemithyl
4
bemithyl treatment
4
treatment carried
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!